This category encompasses research into a drug for PLN (located on the right side of the overview). This category can be further divided into three different research directions:

• Research area DNA:

This subcategory includes research aimed at correcting the mutation in the DNA using DNA editing techniques such as CRISPR-Cas and Prime Editing.

• Research area RNA:

This subcategory represents research conducted to explore the possibilities of intercepting the faulty mRNA (messenger in the cell) so that no faulty PLN protein can be produced.

• Research area existing medication:

This subcategory describes research that focuses on investigating the possibilities of using existing medication as a drug for PLN.